Mehndiratta Manmohan, Garg Rohit K, Pandey Sanjay
Department of Neurology, G.B. Pant Hospital, New Delhi, India.
J Assoc Physicians India. 2011 May;59:302-8, 313.
Parkinson's disease (PD) is the second most common neurodegenerative disorder, after Alzheimer's disease. The cardinal clinical features of PD include asymmetric onset of bradykinesia, rigidity, and resting tremor. Most patients of idiopathic PD present with one or more of the cardinal motor features. Apart from these, various nonmotor symptoms (NMS) also occur in PD and constitute a major clinical challenge, as they are common, but often overshadowed by the dominance of motor symptoms. NMS can present at any stage of the disease including early and pre-motor phase of PD. Several NMS such as olfactory dysfunction, constipation, REM behaviour disorder, depression may antedate the motor signs, symptoms and diagnosis of PD by a number of years. Since, NMS add significantly to the overall disability caused by PD, their early recognition and treatment may go a long way in improving the quality of life of PD patients as well as the economic burden on the carers. The identification of NMS can be improved by the application of quantitative and validated instruments and scales for their assessment.
帕金森病(PD)是仅次于阿尔茨海默病的第二常见神经退行性疾病。PD的主要临床特征包括运动迟缓、僵硬和静止性震颤的不对称发作。大多数特发性PD患者表现出一种或多种主要运动特征。除此之外,PD还会出现各种非运动症状(NMS),这构成了一项重大临床挑战,因为它们很常见,但往往被运动症状的主导地位所掩盖。NMS可出现在疾病的任何阶段,包括PD的早期和运动前期。嗅觉功能障碍、便秘、快速眼动睡眠行为障碍、抑郁等几种NMS可能比PD的运动体征、症状和诊断提前数年出现。由于NMS显著增加了PD导致的整体残疾,它们的早期识别和治疗对于改善PD患者的生活质量以及减轻护理人员的经济负担可能大有帮助。通过应用定量且经过验证的评估工具和量表,可以更好地识别NMS。